Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA
mSphere. 2020 Oct 21;5(5):e00869-20. doi: 10.1128/mSphere.00869-20.
The gut microbiota has a key role in determining susceptibility to infections (CDIs). However, much of the mechanistic work examining CDIs in mouse models uses animals obtained from a single source. We treated mice from 6 sources (2 University of Michigan colonies and 4 commercial vendors) with clindamycin, followed by a challenge, and then measured colonization levels throughout the infection. The microbiota were profiled via 16S rRNA gene sequencing to examine the variation across sources and alterations due to clindamycin treatment and challenge. While all mice were colonized 1 day postinfection, variation emerged from days 3 to 7 postinfection with animals from some sources colonized with for longer and at higher levels. We identified bacteria that varied in relative abundance across sources and throughout the experiment. Some bacteria were consistently impacted by clindamycin treatment in all sources of mice, including , , and To identify bacteria that were most important to colonization regardless of the source, we created logistic regression models that successfully classified mice based on whether they cleared by 7 days postinfection using community composition data at baseline, post-clindamycin treatment, and 1 day postinfection. With these models, we identified 4 bacterial taxa that were predictive of whether cleared. They varied across sources () or were altered by clindamycin () or both ( and ). Allowing for microbiota variation across sources better emulates human interindividual variation and can help identify bacterial drivers of phenotypic variation in the context of CDIs. is a leading nosocomial infection. Although perturbation to the gut microbiota is an established risk, there is variation in who becomes asymptomatically colonized, develops an infection, or has adverse infection outcomes. Mouse models of infection (CDI) are widely used to answer a variety of pathogenesis questions. However, the interindividual variation between mice from the same breeding facility is less than what is observed in humans. Therefore, we challenged mice from 6 different breeding colonies with We found that the starting microbial community structures and persistence varied by the source of mice. Interestingly, a subset of the bacteria that varied across sources were associated with how long was able to colonize. By increasing the interindividual diversity of the starting communities, we were able to better model human diversity. This provided a more nuanced perspective of pathogenesis.
肠道微生物群在决定易感性方面起着关键作用 感染(CDI)。然而,在检查小鼠模型中的 CDI 的大部分机制工作中,使用的是来自单一来源的动物。我们用克林霉素治疗来自 6 个来源(密歇根大学的 2 个殖民地和 4 个商业供应商)的小鼠,然后进行 挑战,然后测量整个感染过程中的定植水平。通过 16S rRNA 基因测序来分析微生物组,以检查不同来源的变化以及克林霉素治疗和 挑战引起的变化。虽然所有的老鼠在感染后 1 天都被定植,但从感染后 3 天到 7 天,来自某些来源的老鼠的定植出现了差异,有些老鼠定植的时间更长,水平更高。我们发现了在不同来源和整个实验中相对丰度变化的细菌。一些细菌在所有来源的小鼠中都受到克林霉素治疗的一致影响,包括 、 、 和 为了确定无论来源如何对定植最重要的细菌,我们创建了逻辑回归模型,该模型使用基线、克林霉素治疗后和 1 天后的群落组成数据成功地根据 7 天内是否清除 来对小鼠进行分类。使用这些模型,我们确定了 4 种细菌分类群可以预测 是否被清除。它们在来源之间有所不同(),或者被克林霉素()或两者( 和 )改变。允许微生物群在来源之间变化可以更好地模拟人类个体间的变异性,并有助于确定 CDI 背景下表型变异性的细菌驱动因素。是一种主要的医院获得性感染。尽管肠道微生物群的扰动是一个既定的风险,但谁会无症状定植、发展感染或出现不良感染结果存在差异。感染(CDI)的小鼠模型广泛用于回答各种 发病机制问题。然而,来自同一繁殖设施的小鼠之间的个体间差异小于人类观察到的差异。因此,我们用 挑战来自 6 个不同繁殖殖民地的小鼠。我们发现,起始微生物群落结构和 定植的持久性因小鼠的来源而异。有趣的是,跨来源变化的细菌的一部分与 定植时间的长短有关。通过增加起始群落的个体间多样性,我们能够更好地模拟人类的多样性。这提供了一个更细致入微的发病机制视角。